Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) FCF Margin (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed FCF Margin for 4 consecutive years, with 160.69% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 8472.0% to 160.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 152.38% through Dec 2025, down 7393.0% year-over-year, with the annual reading at 152.38% for FY2025, 7393.0% down from the prior year.
  • FCF Margin for Q4 2025 was 160.69% at bioAffinity Technologies, up from 171.27% in the prior quarter.
  • The five-year high for FCF Margin was 65.09% in Q2 2024, with the low at 169528.23% in Q1 2023.
  • Average FCF Margin over 4 years is 27684.25%, with a median of 171.27% recorded in 2025.
  • The sharpest move saw FCF Margin surged 16942902bps in 2024, then crashed -14449bps in 2025.
  • Over 4 years, FCF Margin stood at 55440.58% in 2022, then skyrocketed by 100bps to 72.42% in 2023, then dropped by -5bps to 75.97% in 2024, then tumbled by -112bps to 160.69% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 160.69%, 171.27%, and 209.58% for Q4 2025, Q3 2025, and Q2 2025 respectively.